查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1602334

API 中間體市場：按類型、原料、應用和最終用戶分類 - 全球預測 2025-2030

API Intermediates Market by Type (Bulk Drug Intermediates, Chemical Intermediates), Raw Material (Carbonyl, Chloro, Nitrile), Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

API中間體市場2023年估值為1786.3億美元，預計到2024年將達到1926.5億美元，複合年成長率為7.85%，到2030年將達到3032.3億美元。

API中間體是製藥業的重要成分，是用於合成活性藥物成分（API）的化合物或藥物。它是藥品製造多步驟過程中的關鍵步驟，提供原料或稀釋劑來源與最終活性成分之間的關聯。對 API 中間體的需求源於它們在最佳化最終藥物的功效、安全性和穩定性、促進藥物進步和大規模生產方面的作用。這些中間體在從非處方藥到處方藥的廣泛藥物類別中具有應用，並且是新療法和學名藥的基礎。最終用途範圍主要針對以藥物開發和生產為重點的製藥公司和研究機構。

主要市場統計
基準年[2023] 1786.3億美元
預測年份 [2024] 1926.5億美元
預測年份 [2030] 3032.3億美元
複合年成長率（%） 7.85%

API中間體市場受到學名藥需求增加、生物製藥技術進步以及全球需要新治療方法的慢性疾病數量增加等因素的顯著影響。持續的技術創新正在推動需求，尤其是需要專門中間體的複雜原料藥，商機比比皆是。公司可以透過投資人工智慧和機器學習等最尖端科技來最佳化流程，並加強與生物技術公司的合作以促進研發進步，從而利用機會。然而，市場成長面臨限制，例如嚴格的監管要求會延長核准時間並增加開發成本。此外，原物料價格波動也是一個持續的挑戰。

為了緩解這些挑戰，企業應該專注於綠色化學等永續實踐。技術創新部分包括提高生產流程的可擴展性以及利用CRISPR和其他基因技術開發新的中間體。開放這個競爭激烈但前景廣闊的市場需要策略遠見，特別注重透過策略夥伴關係關係擴大產品組合，並做出進入新興市場以挖掘開拓潛力的決策。

市場動態：揭示快速發展的 API 中間體市場的關鍵市場洞察

API 中間體市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 慢性病流行和對學名藥的需求
    • 政府促進生物製藥生產活動的舉措
    • 擴大採用罕見疾病和治療罕見疾病的特殊原料藥
  • 市場限制因素
    • API 中間體的複雜採購與智慧財產權問題
  • 市場機會
    • API中間體的合成與加工研究進展
    • 專門從事原料藥製造的受託製造廠商的興起
  • 市場問題
    • API 中間體安全與品質的監管複雜性

波特五力：駕馭 API 中間體市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點，避免潛在的挑戰，確保更強大的市場地位。

PESTLE分析：了解API中間體市場的外部影響

外部宏觀環境因素在塑造 API 中間體市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析：了解API中間體市場的競爭格局

API 中間體市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：API 中間體市場供應商績效評估

FPNV 定位矩陣是評估 API 中間體市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製 API 中間體市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，API 中間體市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1.市場滲透率：對當前市場環境的詳細審查，主要企業的廣泛資料，評估他們在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性病的流行和對學名藥的需求
      • 政府促進生物製藥生產活動的舉措
      • 更多地採用專門的 API 來治療罕見和不治之症
    • 抑制因素
      • 取得 API 中間體的複雜性和智慧財產權問題
    • 機會
      • API中間體的合成與加工研究進展
      • 專門從事 API 製造的契約製造組織的興起
    • 任務
      • API 中間體安全與品質的監管複雜性
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章 API 中間體市場：依類型

  • 介紹
  • 原料藥中間體
  • 化學中間體

第7章原料藥中間體市場：依原料分類

  • 介紹
  • 羰
  • 庫洛洛
  • 丁腈橡膠
  • 硝基

第8章原料藥中間體市場：依應用分類

  • 介紹
  • 止痛藥
  • 抗感染
  • 抗癌藥
  • 抗糖尿病藥
  • 心血管藥物

第 9 章 API 中間體市場：依最終使用者分類

  • 介紹
  • 生物技術和製藥公司
  • 首席行銷長
  • 研究所

第10章 美洲原料藥中間體市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太原料藥中間體市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東及非洲原料藥中間體市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Sigachi Industries 進軍 API 業務並收購 Trimax Bio Sciences 多數股權
    • 勃林格殷格翰與德國總理奧拉夫舒爾茨舉行耗資 2.85 億歐元的研發中心奠基儀式
    • FLAMMA未來三年投資2億美元
  • 戰略分析和建議

公司名單

  • Aarti Pharmalabs Limited
  • Actylis
  • Alzchem Group
  • API Corporation by UBE Corp.
  • Atul Ltd.
  • Aurobindo Pharma
  • BASF SE
  • Cambrex Corp.
  • Cation Pharma
  • Divi's Laboratories Limited
  • Dr. Reddy's Laboratories Ltd.
  • Espee Group
  • Evonik Industries AG
  • Flamma Group
  • Hikal Ltd.
  • Kaneka Corporation
  • Levachem Company Ltd.
  • Lupin Ltd.
  • Nectar Lifesciences Ltd.
  • Noah Chemicals
  • Pfizer Inc.
  • Proviron Holding NV
  • Sandoo Pharmaceuticals and Chemicals Co., Ltd.
  • Sandoz International GmbH by Novartis AG
  • Sanofi
  • Sarex
  • Shree Ganesh Remedies Ltd.
  • Sumitomo Chemical Co., Ltd.
  • Vertellus
  • ZCL Chemicals Ltd. by Advent International
Product Code: MRR-CF699CF4142A

The API Intermediates Market was valued at USD 178.63 billion in 2023, expected to reach USD 192.65 billion in 2024, and is projected to grow at a CAGR of 7.85%, to USD 303.23 billion by 2030.

API intermediates, essential components in the pharmaceutical industry, are compounds or agents used in the synthesis of active pharmaceutical ingredients (APIs). They represent a critical step in the multi-stage process of drug manufacturing, bridging raw materials and diluted sources with the final active ingredients. The necessity of API intermediates arises from their role in optimizing the efficacy, safety, and stability of final pharmaceutical products, thus facilitating the advancement and mass production of medications. These intermediates find applications across a wide range of medication categories-spanning from over-the-counter drugs to prescription medications-serving as the foundation for novel therapies and generic products. The end-use scope primarily targets pharmaceutical companies and research institutes prioritizing drug development and production.

KEY MARKET STATISTICS
Base Year [2023] USD 178.63 billion
Estimated Year [2024] USD 192.65 billion
Forecast Year [2030] USD 303.23 billion
CAGR (%) 7.85%

The API intermediates market is significantly influenced by factors such as increased demand for generic drugs, advancements in biopharmaceutical technologies, and the rise of chronic diseases worldwide necessitating novel therapies. Opportunities abound as continuous innovation drives demand, particularly in complex APIs requiring specialized intermediates. Companies can tap into opportunities by investing in cutting-edge technologies like AI and machine learning for process optimization and increasing collaborations with biotech firms for R&D advancements. However, market growth faces limitations such as stringent regulatory requirements, which elongate approval times and raise development costs. Additionally, the volatility in raw material prices poses a consistent challenge.

To mitigate challenges, businesses should focus on sustainable practices such as green chemistry, which reduces environmental impact and aligns with regulatory shifts favoring eco-friendly processes. Areas for innovation include enhancing the scalability of production processes and leveraging CRISPR and other genetic technologies for the development of novel intermediates. Navigating this competitive, yet promising market requires strategic foresight, with a particular emphasis on expanding portfolios through strategic partnerships and determining market entry in emerging economies to harness under-tapped potential.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving API Intermediates Market

The API Intermediates Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of chronic diseases and need for generic drugs
    • Government initiatives promoting biopharmaceutical manufacturing activities
    • Increased adoption of specialty APIs for rare and orphan disease treatment
  • Market Restraints
    • Complicated sourcing of API intermediates and intellectual property concerns
  • Market Opportunities
    • Advancements in synthesizing and processing of API intermediates
    • Rise of contract manufacturing organizations specializing in API production
  • Market Challenges
    • Regulatory complexity concerning the safety and quality of API intemediates

Porter's Five Forces: A Strategic Tool for Navigating the API Intermediates Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the API Intermediates Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the API Intermediates Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the API Intermediates Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the API Intermediates Market

A detailed market share analysis in the API Intermediates Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the API Intermediates Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the API Intermediates Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the API Intermediates Market

A strategic analysis of the API Intermediates Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the API Intermediates Market, highlighting leading vendors and their innovative profiles. These include Aarti Pharmalabs Limited, Actylis, Alzchem Group, API Corporation by UBE Corp., Atul Ltd., Aurobindo Pharma, BASF SE, Cambrex Corp., Cation Pharma, Divi's Laboratories Limited, Dr. Reddy's Laboratories Ltd., Espee Group, Evonik Industries AG, Flamma Group, Hikal Ltd., Kaneka Corporation, Levachem Company Ltd., Lupin Ltd., Nectar Lifesciences Ltd., Noah Chemicals, Pfizer Inc., Proviron Holding NV, Sandoo Pharmaceuticals and Chemicals Co., Ltd., Sandoz International GmbH by Novartis AG, Sanofi, Sarex, Shree Ganesh Remedies Ltd., Sumitomo Chemical Co., Ltd., Vertellus, and ZCL Chemicals Ltd. by Advent International.

Market Segmentation & Coverage

This research report categorizes the API Intermediates Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Bulk Drug Intermediates and Chemical Intermediates.
  • Based on Raw Material, market is studied across Carbonyl, Chloro, Nitrile, and Nitro.
  • Based on Application, market is studied across Analgesics, Anti-Infective Drugs, Anticancer Drugs, Antidiabetic Drugs, and Cardiovascular Drugs.
  • Based on End User, market is studied across Biotech & Pharmaceutical Companies, CMO, and Research Laboratories.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of chronic diseases and need for generic drugs
      • 5.1.1.2. Government initiatives promoting biopharmaceutical manufacturing activities
      • 5.1.1.3. Increased adoption of specialty APIs for rare and orphan disease treatment
    • 5.1.2. Restraints
      • 5.1.2.1. Complicated sourcing of API intermediates and intellectual property concerns
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in synthesizing and processing of API intermediates
      • 5.1.3.2. Rise of contract manufacturing organizations specializing in API production
    • 5.1.4. Challenges
      • 5.1.4.1. Regulatory complexity concerning the safety and quality of API intemediates
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. API Intermediates Market, by Type

  • 6.1. Introduction
  • 6.2. Bulk Drug Intermediates
  • 6.3. Chemical Intermediates

7. API Intermediates Market, by Raw Material

  • 7.1. Introduction
  • 7.2. Carbonyl
  • 7.3. Chloro
  • 7.4. Nitrile
  • 7.5. Nitro

8. API Intermediates Market, by Application

  • 8.1. Introduction
  • 8.2. Analgesics
  • 8.3. Anti-Infective Drugs
  • 8.4. Anticancer Drugs
  • 8.5. Antidiabetic Drugs
  • 8.6. Cardiovascular Drugs

9. API Intermediates Market, by End User

  • 9.1. Introduction
  • 9.2. Biotech & Pharmaceutical Companies
  • 9.3. CMO
  • 9.4. Research Laboratories

10. Americas API Intermediates Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific API Intermediates Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa API Intermediates Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Sigachi Industries Forays into API business, Acquires Majority Stake in Trimax Bio Sciences
    • 13.3.2. Boehringer Ingelheim and German Chancellor Olaf Scholz Lay The Foundation Stone for 285 million EUR Innovation Center
    • 13.3.3. FLAMMA to Invest USD 200 Million Over the Next 3 Years
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aarti Pharmalabs Limited
  • 2. Actylis
  • 3. Alzchem Group
  • 4. API Corporation by UBE Corp.
  • 5. Atul Ltd.
  • 6. Aurobindo Pharma
  • 7. BASF SE
  • 8. Cambrex Corp.
  • 9. Cation Pharma
  • 10. Divi's Laboratories Limited
  • 11. Dr. Reddy's Laboratories Ltd.
  • 12. Espee Group
  • 13. Evonik Industries AG
  • 14. Flamma Group
  • 15. Hikal Ltd.
  • 16. Kaneka Corporation
  • 17. Levachem Company Ltd.
  • 18. Lupin Ltd.
  • 19. Nectar Lifesciences Ltd.
  • 20. Noah Chemicals
  • 21. Pfizer Inc.
  • 22. Proviron Holding NV
  • 23. Sandoo Pharmaceuticals and Chemicals Co., Ltd.
  • 24. Sandoz International GmbH by Novartis AG
  • 25. Sanofi
  • 26. Sarex
  • 27. Shree Ganesh Remedies Ltd.
  • 28. Sumitomo Chemical Co., Ltd.
  • 29. Vertellus
  • 30. ZCL Chemicals Ltd. by Advent International

LIST OF FIGURES

  • FIGURE 1. API INTERMEDIATES MARKET RESEARCH PROCESS
  • FIGURE 2. API INTERMEDIATES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL API INTERMEDIATES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL API INTERMEDIATES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL API INTERMEDIATES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL API INTERMEDIATES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL API INTERMEDIATES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL API INTERMEDIATES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES API INTERMEDIATES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES API INTERMEDIATES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. API INTERMEDIATES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. API INTERMEDIATES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. API INTERMEDIATES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL API INTERMEDIATES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL API INTERMEDIATES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. API INTERMEDIATES MARKET DYNAMICS
  • TABLE 7. GLOBAL API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL API INTERMEDIATES MARKET SIZE, BY BULK DRUG INTERMEDIATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL API INTERMEDIATES MARKET SIZE, BY CHEMICAL INTERMEDIATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL API INTERMEDIATES MARKET SIZE, BY CARBONYL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL API INTERMEDIATES MARKET SIZE, BY CHLORO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL API INTERMEDIATES MARKET SIZE, BY NITRILE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL API INTERMEDIATES MARKET SIZE, BY NITRO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL API INTERMEDIATES MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL API INTERMEDIATES MARKET SIZE, BY ANTI-INFECTIVE DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL API INTERMEDIATES MARKET SIZE, BY ANTICANCER DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL API INTERMEDIATES MARKET SIZE, BY ANTIDIABETIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL API INTERMEDIATES MARKET SIZE, BY CARDIOVASCULAR DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL API INTERMEDIATES MARKET SIZE, BY BIOTECH & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL API INTERMEDIATES MARKET SIZE, BY CMO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL API INTERMEDIATES MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES API INTERMEDIATES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 193. API INTERMEDIATES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 194. API INTERMEDIATES MARKET, FPNV POSITIONING MATRIX, 2023